These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12472099)

  • 21. [Adverse drug reactions. Incidence and monitoring].
    Kampmann JP; Hansen JE
    Ugeskr Laeger; 1979 Jan; 141(3):168-73. PubMed ID: 366844
    [No Abstract]   [Full Text] [Related]  

  • 22. [Adverse drug reactions in pregnant women].
    Lacroix I; Cabou C; Montastruc JL; Damase-Michel C
    Therapie; 2007; 62(5):455-60. PubMed ID: 18206108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adverse drug reaction monitoring in Jena--experiences of a regionalized pharmacovigilance centre.
    Hoffmann A; Hippius M; Sicker T
    Exp Toxicol Pathol; 1998 Sep; 50(4-6):453-7. PubMed ID: 9784022
    [No Abstract]   [Full Text] [Related]  

  • 24. [Drugs implicated in iatrogenic lung pathology. The STudy Group of Iatrogenic Lung Pathology].
    Foucher P; Biour M; Godard P; Ollagnier M; Mayaud C; Camus P
    Rev Mal Respir; 1996 Dec; 13(6):616-29. PubMed ID: 9036513
    [No Abstract]   [Full Text] [Related]  

  • 25. Reporting adverse reactions to medicines.
    Ferguson R
    Nurs N Z; 1999 Dec-2000 Jan; 5(11):11. PubMed ID: 12008207
    [No Abstract]   [Full Text] [Related]  

  • 26. [Evaluation of declarations of severe adverse effects from the publication of the decree dated 13 March 1995 about the organisation of pharmacovigilance].
    Lelouet H; Morin M; Trenque T; Bidault I; Castot A; Alexandre JM
    Therapie; 1996; 51(5):555-6. PubMed ID: 9138393
    [No Abstract]   [Full Text] [Related]  

  • 27. New Zealand Committee on Adverse Drug Reactions: reactions reported 1965-1968.
    N Z Med J; 1969 Feb; 69(441):96-9. PubMed ID: 5252211
    [No Abstract]   [Full Text] [Related]  

  • 28. [Pharmacovigilance].
    Livio F; Renard D; Buclin T
    Rev Med Suisse; 2012 Jan; 8(324):116-9. PubMed ID: 23185821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The nature of the scientific evidence leading to drug withdrawals for pharmacovigilance reasons in France.
    Olivier P; Montastruc JL
    Pharmacoepidemiol Drug Saf; 2006 Nov; 15(11):808-12. PubMed ID: 16700082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nurses improve medication safety with medication allergy and adverse drug reports.
    Valente S; Murray L; Fisher D
    J Nurs Care Qual; 2007; 22(4):322-7. PubMed ID: 17873729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of an electronic medical record system for mandatory reporting of drug hypersensitivity reactions has been shown to improve the management of patients in the university hospital in Korea.
    Park CS; Kim TB; Kim SL; Kim JY; Yang KA; Bae YJ; Cho YS; Moon HB
    Pharmacoepidemiol Drug Saf; 2008 Sep; 17(9):919-25. PubMed ID: 18470952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Drug consumption and adverse reactions in a department of internal medicine].
    Hess J; Andersen T; Nielsen IK; Christiansen LV; Folkenberg F; Osterlind AW; Olsen L; Kampmann JP; Hansen JE
    Ugeskr Laeger; 1979 Jan; 141(3):174-7. PubMed ID: 760287
    [No Abstract]   [Full Text] [Related]  

  • 33. Drug hypersensitivities: definition, epidemiology and risk factors.
    Demoly P; Gomes ER
    Eur Ann Allergy Clin Immunol; 2005 Jun; 37(6):202-6. PubMed ID: 16156397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Making the most of spontaneous adverse drug reaction reporting.
    Waller PC
    Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):320-3. PubMed ID: 16611209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse drug reactions and the autopsy. Prevalence and perspective.
    Gotti EW
    Arch Pathol; 1974 Apr; 97(4):201-4. PubMed ID: 4814703
    [No Abstract]   [Full Text] [Related]  

  • 36. Data mining for signals in spontaneous reporting databases: proceed with caution.
    Stephenson WP; Hauben M
    Pharmacoepidemiol Drug Saf; 2007 Apr; 16(4):359-65. PubMed ID: 17019675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Building an ontology of adverse drug reactions for automated signal generation in pharmacovigilance.
    Henegar C; Bousquet C; Lillo-Le Louët A; Degoulet P; Jaulent MC
    Comput Biol Med; 2006; 36(7-8):748-67. PubMed ID: 16185681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Adverse drug reactions and poisoning as a cause of admission to a medical clinic].
    Beermann B; Biörck G; Groschinsky-Grind M
    Lakartidningen; 1978 Mar; 75(10):958-60. PubMed ID: 628247
    [No Abstract]   [Full Text] [Related]  

  • 39. [Adverse reactions to drugs in gastroenterological patients during their hospitalization].
    Naranjo CA; Sanhueza P
    Rev Med Chil; 1973 Jun; 101(6):456-63. PubMed ID: 4764561
    [No Abstract]   [Full Text] [Related]  

  • 40. [Negative response to medications: what to do].
    Bernardini R
    Minerva Pediatr; 2009 Dec; 61(6):793-6. PubMed ID: 19935555
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.